Last updated on May 2019

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.


Brief description of study

Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.

Detailed Study Description

The purpose of this registry is to evaluate clinical outcome and safety data in subjects with drug resistant epilepsy treated with the VNS Therapy System. The study will collect outcomes for subjects treated with VNS Therapy in a real-world setting.

Clinical Study Identifier: NCT03529045

Find a site near you

Start Over

Hawaii Pacific Neuroscience

Honolulu, HI United States
  Connect »

Winchester Medical Center

Winchester, VA United States
  Connect »

Onsite Clinical

Charlotte, NC United States
  Connect »

St. Mary's Hospital

Grand Junction, CO United States
  Connect »

Via Christi Health

Wichita, KS United States
  Connect »

Albany Medical Center

Albany, NY United States
  Connect »

State University of New York

Syracuse, NY United States
  Connect »

Onsite Clinical Solutions, LLC

Charlotte, NC United States
  Connect »

Allegheny Neurology Associates

Pittsburgh, PA United States
  Connect »

West Virginia University

Morgantown, WV United States
  Connect »

The Alfred Hospital

Melbourne, Australia
  Connect »

UCL Saint-Luc

Brussels, Belgium
  Connect »

Kempenhaege

Heeze, Netherlands
  Connect »

Southmead Hospital

Bristol, United Kingdom
  Connect »

Royal Victoria Infirmary Hospital

Newcastle Upon Tyne, United Kingdom
  Connect »

Royal Hallamshire Hospital

Sheffield, United Kingdom
  Connect »